RJFSA
MRNA icon

Raymond James Financial Services Advisors’s Moderna MRNA Stock Holding History

Raymond James Financial Services Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,700
Closed -$34K – 3360
2022
Q1 		$34K Buy
+15,700
New +$2.64M ﹤0.01% 3223
2021
Q3 		– Sell
-25,600
Closed -$1.19M – 3371
2021
Q2 		$1.19M Buy
+25,600
New +$4.57M ﹤0.01% 1836

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Financial Services Advisors's MRNA Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Moderna (MRNA) stake by 9.4% in Q3 2024, buying an estimated $667K and bringing the position to 84,193 shares worth $5.63M. The position accounts for 0.01% of the portfolio, ranked #1158.

Raymond James Financial Services Advisors first reported a position in MRNA in Q2 2019 and has held it in 22 quarters since. The position peaked at $42.5M in Q3 2021. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Raymond James Financial Services Advisors held 84,193 shares of Moderna worth $5.63M as of Q3 2024.
  • Raymond James Financial Services Advisors bought 7,262 Moderna shares in Q3 2024, an estimated $667K.
  • Moderna made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1158 holding.
  • Raymond James Financial Services Advisors first reported a position in Moderna in Q2 2019 and has held it in 22 quarters since.
  • Raymond James Financial Services Advisors's Moderna position peaked at $42.5M in Q3 2021.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.